% | $
Quotes you view appear here for quick access.

Diadexus, Inc. Message Board

  • smelky_kid smelky_kid Sep 17, 2013 11:37 AM Flag

    There is a buzz building....

    Normally, you have a pivotal event that is make it or break it for a tiny biotech. In this case, we have an undervalued company, with revenues growing at 28% per year, regardless of the success of Darapladib. Business as usual will keep this company moving. Darapladib is a monster in the closet. A successful phase III for Glaxo means revenues could surge by a factor of 30, overnight. There is nothing better than being a shareholder of Diadexus.....

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • moto1960 Sep 17, 2013 10:12 PM Flag

      Looks like that Seeking Alpha article appeared anytime you pull up a GSK quote on any major financial website. That surely contributed to the 'buzz' today. Afterall, who wouldn't want to purchase what could be GSK's little brother. Now all we have to do is wait for the paternity test (aka Darapladib results). MDLAND~

    • Started a new position yesterday for new ride north to 5-10-15-20 on darapladib results. This one's been good to me every time I buy it, next day shoots up. The magic touch.

      Sentiment: Strong Buy

1.42-0.09(-5.96%)11:48 AMEST